Search clinical trials for: Castrate-resistant
Total 17 results
-
St Vincent's Hospital, SydneyRecruitingCastration-resistant Prostate Cancer | Homologous Recombination DeficiencyAustralia
-
AmgenActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Karyopharm Therapeutics IncCompletedSolid TumorUnited States, Denmark, Canada
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
SOTIO a.s.TerminatedCastration-resistant Prostate CancerCzechia
-
Oncoethix GmbHCompletedTriple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castrate-resistant Prostate Cancer | CRPC | NUT Midline Carcinoma | Non-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
University of HawaiiTerminated
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Case Comprehensive Cancer CenterWithdrawnCastrate-resistant Metastatic Prostate Cancer
-
The Christie NHS Foundation TrustAstraZenecaUnknown